Skip to Main Content
Table 1

Contrasting clinical benefits and improved outcomes with adverse outcomes/risks associated with the use of incretin-based glucose-lowering medications (a, GLP-1 receptor agonists; b, inhibitors of DPP-4)

Contrasting clinical benefits and improved outcomes with adverse outcomes/risks associated with the use of incretin-based glucose-lowering medications (a, GLP-1 receptor agonists; b, inhibitors of DPP-4)
Contrasting clinical benefits and improved outcomes with adverse outcomes/risks associated with the use of incretin-based glucose-lowering medications (a, GLP-1 receptor agonists; b, inhibitors of DPP-4)
Close Modal

or Create an Account

Close Modal
Close Modal